ESC 365 - Qiliqiangxin in patients with heart failure and reduced ejection fraction - the QUEST study

ESC Professional Premium Access

Qiliqiangxin in patients with heart failure and reduced ejection fraction - the QUEST study

Session: HOT LINE 2

Topic: Pharmacotherapy

Speaker: Professor X. Li (Nanjing, CN)

Event: ESC Congress 2023

Congress Presentation

Add to my library

About the speaker

Professor Xinli Li

The First Affiliated Hospital of Nanjing Medical University, Nanjing (China)

2 presentations

0 follower

11 more presentations in this session

Discussant review - QUEST

Speaker: Professor C. Lam (Singapore, SG)

Panel discussion - QUEST

BUDAPEST CRT Upgrade: Cardiac resynchronisation therapy upgrade in heart failure with right ventricular pacing - a multicentre, randomised, controlled trial

Speaker: Professor B. Merkely (Budapest, HU)

Discussant review - BUDAPEST CRT Upgrade

Speaker: Professor C. Linde (Stockholm, SE)

Panel discussion - BUDAPEST CRT Upgrade

Access the full session

HOT LINE 2

Speakers: Professor X. Li, Professor C. Lam, Professor B. Merkely, Professor C. Linde

About the event

ESC Congress 2023

25 August - 28 August 2023

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources